The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Drug-Induced Autoimmune Hepatitis: Response to Corticosteroids and Lack of Relapse After Cessation of Steroids
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A limited number of studies comparing liver histology between DI-ALH and AIH have been undertaken.
“A limited number of studies comparing liver histology between DI-ALH and AIH have been undertaken.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [17]
There is very limited data on the dose of corticosteroids used to treat DI-ALH in the published literature.
“There is very limited data on the dose of corticosteroids used to treat DI-ALH in the published literature.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [17]
Histological characteristics do not seem to enable distinction between DI-ALH and AIH.
“Histological characteristics do not seem to enable distinction between these entities.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [17]
In DI-ALH, after withdrawal of the causative agent and with institution of immunosuppression, the outcome is generally good in most cases, with a low risk of relapse or progression to chronic liver injury.
“After the withdrawal of the causative agent and with institution of immunosuppression, the outcome in DI-ALH is generally good in most cases, with a low risk of relapse or progression to chronic liver injury, as reported in different studies with heterogeneous follow-up (Table 1).14,17,34,35,50”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [17]
Most cases of DI-ALH rarely relapse in the long-term follow-up after discontinuation of corticosteroid or immunosuppressive therapy.
“Unlike AIH, most cases of DI-ALH rarely relapse in the long-term follow-up after the discontinuation of corticosteroid or immunosuppressive therapy [83,84], which is the key information that indicates the probability of DI-ALH, particularly for patients with a history of classical drug exposure.”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [84]
Citations
Cites
Björnsson, E. S., Bergmann, O. M., Björnsson, H. K., Kvaran, R. B., & Olafsson, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.006 · Cited by 865
Self-citation
Flagged first, then by citations
Research works printed but not linked: 6
- Björnsson, 2010, Drug-induced autoimmune hepatitis: clinical characteristics and prognosis, Hepatology, 51, 2040, 10.1002/hep.23588 · DOI · Paper page
- Björnsson, 2015, The risk of drug-induced liver injury from tumor necrosis factor (TNF)-alpha-antagonists, Clin Gastroenterol Hepatol, 13, 602, 10.1016/j.cgh.2014.07.062 · DOI · Paper page
- de Boer, 2017, Features of autoimmune hepatitis in patients with drug-induced liver injury, Clin Gastroenterol Hepatol, 15, 103, 10.1016/j.cgh.2016.05.043 · DOI · Paper page
- Björnsson, 2016, A prospective study on the causes of notably raised alanine aminotransferase, Scand J Gastroenterol, 51, 594, 10.3109/00365521.2015.1121516 · DOI
- Danan, 1993, Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
- Suzuki, 2011, The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis vs. drug-induced liver injury, Hepatology, 54, 931, 10.1002/hep.24481 · DOI
Cited by
Sorted by citations
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J., Reddy, K. R., & on behalf of the Practice Parameters Committee of the American College of Gastroenterology (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001259 · Cited by 430
Andrade, R. J., Aithal, G. P., de Boer, Y. S., Liberal, R., Gerbes, A., Regev, A., Terziroli Beretta-Piccoli, B., Schramm, C., Kleiner, D. E., De Martin, E., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.033 · Cited by 166
Biologic and checkpoint inhibitor‐induced liver injury: a systematic literature review
Shah, P., Sundaram, V., & Björnsson, E. (2020) · Hepatology Communications · doi:10.1002/hep4.1465 · Cited by 64
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update
Mao, Y., Ma, S., Liu, C., Liu, X., Su, M., Li, D., Li, Y., Chen, G., Chen, J., Chen, J., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10633-7 · Cited by 62
Metadata
- Authors
- Björnsson, E. S., Bergmann, O., Jonasson, J. G., Grondal, G., Gudbjornsson, B., & Olafsson, S.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 15
- Issue
- 10
- Pages
- 1635-1636
- ISSN
- 1542-3565
- Cited by
- 84
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
